PMC:7253233 / 3359-3555 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"141","span":{"begin":25,"end":33},"obj":"Species"},{"id":"150","span":{"begin":39,"end":47},"obj":"Disease"},{"id":"151","span":{"begin":71,"end":87},"obj":"Disease"},{"id":"152","span":{"begin":114,"end":143},"obj":"Disease"},{"id":"153","span":{"begin":145,"end":165},"obj":"Disease"},{"id":"154","span":{"begin":171,"end":195},"obj":"Disease"}],"attributes":[{"id":"A141","pred":"tao:has_database_id","subj":"141","obj":"Tax:9606"},{"id":"A150","pred":"tao:has_database_id","subj":"150","obj":"MESH:C000657245"},{"id":"A151","pred":"tao:has_database_id","subj":"151","obj":"MESH:D034721"},{"id":"A152","pred":"tao:has_database_id","subj":"152","obj":"MESH:D002561"},{"id":"A153","pred":"tao:has_database_id","subj":"153","obj":"MESH:D001927"},{"id":"A154","pred":"tao:has_database_id","subj":"154","obj":"MESH:D004421"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In that series, 45.5% of patients with COVID-19 disease who had severe systemic disease burden also suffered from acute cerebrovascular disease, acute encephalopathy, and skeletal muscle symptoms."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T14","span":{"begin":180,"end":186},"obj":"Body_part"}],"attributes":[{"id":"A14","pred":"fma_id","subj":"T14","obj":"http://purl.org/sig/ont/fma/fma32558"}],"text":"In that series, 45.5% of patients with COVID-19 disease who had severe systemic disease burden also suffered from acute cerebrovascular disease, acute encephalopathy, and skeletal muscle symptoms."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T32","span":{"begin":39,"end":47},"obj":"Disease"},{"id":"T33","span":{"begin":71,"end":87},"obj":"Disease"},{"id":"T34","span":{"begin":120,"end":143},"obj":"Disease"},{"id":"T35","span":{"begin":151,"end":165},"obj":"Disease"}],"attributes":[{"id":"A32","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A33","pred":"mondo_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/MONDO_0015938"},{"id":"A34","pred":"mondo_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/MONDO_0011057"},{"id":"A35","pred":"mondo_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/MONDO_0005560"}],"text":"In that series, 45.5% of patients with COVID-19 disease who had severe systemic disease burden also suffered from acute cerebrovascular disease, acute encephalopathy, and skeletal muscle symptoms."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T36","span":{"begin":171,"end":186},"obj":"http://purl.obolibrary.org/obo/UBERON_0001134"},{"id":"T37","span":{"begin":171,"end":186},"obj":"http://purl.obolibrary.org/obo/UBERON_0014892"},{"id":"T38","span":{"begin":171,"end":186},"obj":"http://www.ebi.ac.uk/efo/EFO_0000888"}],"text":"In that series, 45.5% of patients with COVID-19 disease who had severe systemic disease burden also suffered from acute cerebrovascular disease, acute encephalopathy, and skeletal muscle symptoms."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T20","span":{"begin":145,"end":165},"obj":"Phenotype"}],"attributes":[{"id":"A20","pred":"hp_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/HP_0006846"}],"text":"In that series, 45.5% of patients with COVID-19 disease who had severe systemic disease burden also suffered from acute cerebrovascular disease, acute encephalopathy, and skeletal muscle symptoms."}

{"project":"LitCovid-sentences","denotations":[{"id":"T31","span":{"begin":0,"end":196},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In that series, 45.5% of patients with COVID-19 disease who had severe systemic disease burden also suffered from acute cerebrovascular disease, acute encephalopathy, and skeletal muscle symptoms."}